Dawson James Downgrades Adamis Pharmaceuticals (ADMP) to Neutral

February 27, 2020 7:07 AM EST Send to a Friend
Dawson James analyst Jason Kolbert downgraded Adamis Pharmaceuticals (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login